{
    "success": true,
    "data": {
        "classification": "complex",
        "leverage": false,
        "derivatives": true,
        "swaps": true,
        "inverse": false,
        "replication_method": "physical",
        "ucits": true,
        "type": "ETF",
        "complex_factors": [
            "Derivatives used for direct investment purposes",
            "Counterparty risk from derivatives"
        ],
        "supporting_data": "The ETF is a UCITS fund, which typically presumes non-complexity. It uses optimized physical replication to track the Bloomberg Barclays Euro Corporate Bond Index. However, the Key Investor Information Document explicitly states that 'Financial Derivative Instruments (FDIs) may be used for direct investment purposes.' This indicates that derivatives are integral to achieving the fund's investment objective, rather than solely for efficient portfolio management (EPM). The document also highlights 'Counterparty Risk' as a particular risk, noting that the 'insolvency of any institutions... acting as counterparty to derivatives or other instruments, may expose the Share Class to financial loss.' Under MiFID II, if derivatives are integral to the investment objective and introduce risks like counterparty risk, the instrument is generally classified as complex, as these concepts are difficult for retail investors to understand. The ESMA guidance (CESR/09-295, para 7 & 89) also states that derivatives are generally assumed to be complex. Furthermore, the provided rules explicitly state: 'If any element of Contingent Bonds or any Swap usage is identified then the classification must be complex.' While 'swaps' are not explicitly named as the sole FDI used, the broad statement 'FDIs for direct investment purposes' in a bond ETF, coupled with the identified counterparty risk, strongly implies the potential use of swap-like structures or other complex derivatives for direct investment, thereby triggering the complex classification. Despite the fund's lower overall risk rating (3/7) and physical replication, the specific use and associated risks of derivatives are the primary drivers of its complexity under MiFID II."
    }
}